5901 - 5925 of 9145 Results
Title
Year
-
OPENTitle: A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerabilityJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 69End Page: 74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7770052Citation Count: 38
-
OPENTitle: [11C]dihydrotetrabenazine Positron Emission Tomography in Manganese-Exposed WorkersJournal Name: Journal of Occupational & Environmental MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 62Issue #: 10Start Page: 788End Page: 794Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/jom.0000000000001915Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7786890Citation Count: 6
-
OPENTitle: Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine LearningJournal Name: iSciencePublisher: Elsevier BVVol: 23Issue #: 2Start Page: 100804End Page: 100804Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2019.100804Best OA location URL: https://doi.org/10.1016/j.isci.2019.100804Citation Count: 21
-
OPENTitle: The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?Journal Name: Annals of Translational MedicinePublisher: AME Publishing CompanyVol: 8Issue #: 11Start Page: 719End Page: 719Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/atm.2020.01.117Best OA location URL: https://atm.amegroups.com/article/viewFile/35635/pdfCitation Count: 11
-
OPENTitle: An application of generalized matrix learning vector quantization in neuroimagingJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 197Issue #:Start Page: 105708End Page: 105708Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105708Best OA location URL: https://doi.org/10.1016/j.cmpb.2020.105708Citation Count: 22
-
RESTRICTEDTitle: Theoretical Optimization of Stimulation Strategies for a Directionally Segmented Deep Brain Stimulation Electrode ArrayJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 2Start Page: 359End Page: 371Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2457873Best OA location URL: http://doi.org/10.1109/TBME.2015.2457873Citation Count: 35
-
OPENTitle: The experience of off periods: Qualitative analysis of interviews with persons with Parkinson's and carepartnersJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 31End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.008Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.008Citation Count: 12
-
OPENTitle: Nicotine‐Mediated Rescue of α‐Synuclein Toxicity Requires Synaptic Vesicle Glycoprotein 2 in DrosophilaJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29283Best OA location URL: https://doi.org/10.1002/mds.29283Citation Count: 33
-
OPENTitle: Extracellular Vesicle‐Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2‐FADD in Parkinson's DiseaseJournal Name: Journal of Extracellular BiologyPublisher: WileyVol: 5Issue #: 2Start Page: e70116End Page: e70116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/jex2.70116Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jex2.70116Citation Count: 2
-
OPENTitle: Phenotypical variability in the 6-OHDA mouse model of Parkinson's disease despite consistent and robust nigral lesioningJournal Name: Brain MechanismsPublisher: Elsevier BVVol: 148-150Issue #:Start Page: 202523End Page: 202523Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bramec.2025.202523Best OA location URL: https://doi.org/10.1016/j.bramec.2025.202523Citation Count: 1
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study2018RESTRICTEDTitle: Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 165End Page: 176Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30391-0Citation Count: 109
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study2013RESTRICTEDTitle: Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 141End Page: 149Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(13)70293-xCitation Count: 699
- Characterization of a Parkinson’s disease rat model using an upgraded paraquat exposure paradigm2020RESTRICTEDTitle: Characterization of a Parkinson’s disease rat model using an upgraded paraquat exposure paradigmJournal Name: European Journal of NeurosciencePublisher: WileyVol: 52Issue #: 4Start Page: 3242End Page: 3255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14683Citation Count: 33
-
RESTRICTEDTitle: Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathologyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 131Issue #: 3Start Page: 393End Page: 409Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-015-1526-9Best OA location URL: http://doi.org/10.1007/s00401-015-1526-9Citation Count: 183
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains2010RESTRICTEDTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Citation Count: 169
- α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders2021OPENTitle: α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance DisordersJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26102Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26102Citation Count: 25
-
OPENTitle: Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined SynucleinopathyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.70399Best OA location URL: https://doi.org/10.1002/acn3.70399Citation Count: 1
-
OPENTitle: l‐3,4‐dihydroxyphenylalanine (l‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 37
-
OPENTitle: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 10Start Page: 1816End Page: 1830Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51164Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51164Citation Count: 40
-
OPENTitle: Left Prefrontal Connectivity Links Subthalamic Stimulation with Depressive SymptomsJournal Name: Annals of NeurologyPublisher: WileyVol: 87Issue #: 6Start Page: 962End Page: 975Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25734Best OA location URL: https://doi.org/10.1002/ana.25734Citation Count: 119
-
OPENTitle: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 462End Page: 469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.004Citation Count: 51
-
OPENTitle: Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson'sJournal Name: Annals of NeurologyPublisher: WileyVol: 80Issue #: 5Start Page: 674End Page: 685Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/ana.24781Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24781Citation Count: 278
-
OPENTitle: Variant-to-function dissection of the 17q21.31 locus resolves ANKRD1 as a convergent regulatory targetJournal Name: BMC Medical GenomicsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s12920-026-02375-wBest OA location URL: https://doi.org/10.1186/s12920-026-02375-wCitation Count: 0
-
OPENTitle: Sex differences in LRRK2 G2019S and idiopathic Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 11Start Page: 801End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.489Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.489Citation Count: 38
-
OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson’s disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 61Issue #:Start Page: 102765End Page: 102765Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102765Best OA location URL: https://doi.org/10.1016/j.scr.2022.102765Citation Count: 3